CD274 and neoplasm: Nevertheless, all of these biomarkers have noteworthy drawbacks as follows: PD-L1 is spatially heterogeneous and varies in assay [7]; TMB requires good sequencing resources and cannot be predictive across tumor types [8]; and TIL quantification is usually based on invasive sampling and is lacking standardization [9].